Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy ...

Eli Lilly’s weight loss drug Zepbound outperformed competitor Novo ... a 25% or more body weight reduction due to tirzepatide. By comparison, those who received semaglutide experienced a 16% ...

Injectable GLP-1 receptor agonist drugs Wegovy (semaglutide) and Zepbound (tirzepatide ... first to undertake a head-to-head comparison of the weight loss effectiveness of semaglutide and ...

A new study has compared Wegovy and Zepbound head-to-head in their ability to treat obesity. People taking Eli Lilly’s ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Body image is part physical and part mental. If weight loss alone isn't helping, strategies from body image psychology can ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing cancer ...